Chlamydiae are obligate intracellular bacteria responsible for a number of human and animal disease syndromes, including trachoma, sexually transmitted diseases, and psittacosis (8, 22, 23) . Chlamydiae have a complex life cycle involving the orderly alternation of an infectious metabolically inactive form (elementary body [EB] ) and a noninfectious metabolically active stage (reticulate body) (22) . Injection of high concentrations of the infectious EB causes rapid death in mice, whereas inoculation with much lower concentrations results in a latent infection (20) .
Despite evidence of both enhanced and diminished cellmediated and humoral responses to chlamydiae (6, 10, (16) (17) (18) 25) , the relative importance of various aspects of the immune response in the development of protective immunity to this organism is still unclear. We have adopted a murine model to study acquired immunity to chlamydial infection. In this system, immunity is induced after the injection of low numbers of live organisms. Mice that recover from this primary infection are rendered immune to subsequent challenge with an otherwise lethal high dose of the homologous chlamydial strain but are not protected against infection by unrelated organisms (D. M. Paulnock, R. E. Huebner, L. E. Guagliardi, R. M. Albrecht, and G. I. Byrne, Program Abstr. 25th Intersci. Conf. Antimicrob. Agents Chemother., abstr no. 618, 1985) . The experiments described here were designed to characterize early host responses occurring during the period of development of immunity. Spleen cells from protectively immunized mice exhibited a transient depression in response to the mitogen concanavalin A (ConA) immediately after immunization. However, although proliferative responses were suppressed, cytokine production by these cells remained intact, as measured by production of both interleukin-2 (IL-2) and gamma interferon (IFN--y). Lymphokine-containing supernatant fluids from mitogenstimulated cultures could be shown to inhibit chlamydial growth in vitro and to lyse infected cells. Thus, Chlamydia infection in mice appears to specifically sensitize splenic T lymphocytes, producing effective immunity but concomitantly suppressing T-cell proliferative capacity. These results suggest that independent regulation of T-cell proliferative responses and lymphokine production may occur in vivo as part of an antigen-specific immune response. Such differential modulation of T-cell responses may be a key element in the development of resistance to chlamydiae.
MATERIALS AND METHODS Animals. Adult male C3H mice were obtained from Harlan-Sprague Dawley Co. (Indianapolis, Ind.) and used between 8 and 10 weeks of age. Mice were certified free of murine hepatitis virus at the time of arrival, and the serum was monitored periodically thereafter for the presence of antibodies to the virus. Animals were housed in filter-top cages in AAALAC-approved facilities with restricted access.
Growth of Chlamydia psittaci. C. psittaci (6BC strain) was grown in mouse L cells and harvested by sonicating the trypsinized L cells for 15 min at 40 kHz. Lysates were centrifuged for 30 min at 12,000 x g. Supernatant fluids were discarded, and pellets were suspended in 10 ml of phosphatebuffered saline (PBS) containing 0.25 M sucrose and 2% (vol/vol) heat-inactivated fetal bovine serum (Chlamydia buffer). Cellular debris was cleared by low-speed centrifu-1562 GUAGLIARDI ET AL. gation, and chlamydial suspensions were suspended in Chlamydia buffer (6) . The infectivity titer of each batch of 6BC was determined in L cells by the 50% infective dose method described by Hatch (10) .
Immunization of mice. Mice received 5 x 103 viable EBs serially diluted in PBS from stock suspensions by intramuscular injection in the left flank. Animals immunized in this way survive an otherwise lethal intraperitoneal challenge of 106 EBs administered 10 days after the intramuscular injection (Paulnock et al., 25th ICAAC). Control (mock-immunized) mice were similarly injected with PBS.
Inactivation of C. psittaci with heat or UV light. Some EB preparations were treated with UV light (UV inactivated) before immunization (2) . Infectivity after treatment was assayed by the inclusion-forming-unit technique (15) .
When lymphocyte proliferative responses to chlamydial antigen were tested, the EBs were heat inactivated by incubation in a 56°C water bath for 30 min.
Lymphocyte transformation. Cell suspensions were made from spleens of Chlamydia-sensitized or mock-immunized mice at various times after immunization and pooled for assessment of proliferative responses. Erythrocytes in the splenocyte populations were lysed with hemolytic Gey's solution (19) (1) . Levels of IFN--y detected by this assay in culture supernatant fluids generated in two independent experiments did not vary by more than 10%.
The chlamydiastatic activity of spleen cell supernatant preparations was tested by the method of Byrne and Kreuger (6) . Macrophage target cells for chlamydial infection were harvested by peritoneal lavage from C3H mice injected intraperitoneally 5 days previously with 1 ml of 3% (wt/vol) thioglycolate broth (Difco Laboratories, Detroit, Mich.). Peritoneal cells were collected by centrifugation and suspended in minimal essential medium supplemented with 10% fetal bovine serum (Hazelton). The cells then were plated onto glass cover slips (12-mm diameter, VWR Scientific, Inc., San Francisco, Calif.) in the wells of 24-well plates (Costar). Plated cells were incubated for 30 min at 37°C in a humidified atmosphere of 7% C02, washed free of nonadherent cells, and returned to the incubator with or without the addition of supernatant fluids from ConA-or EB-stimulated spleen cells at various dilutions. After treatment with spleen cell supernatant fluids for 6 h, macrophages were washed extensively and infected with one 50% infective dose of strain 6BC in Hanks balanced salt solution (GIBCO) as previously described (3) . Fresh shown that the activity of the chlamydiastatic factor present in such supernatant preparations is neutralized by antibodies to IFN--y (4). Cytotoxic factor activity in immune and control spleen cell supernatant fluids was determined by a [3H]thymidine release assay using L-cell targets, as previously described (6) . Briefly, L-cell monolayers in 75-cm2 flasks were incubated for 16 to Previous studies have shown that the cytotoxic activity of these supernatant preparations is neutralized by antibodies to IFN--y (5).
Statistical analysis. The proliferative responses of normal and experimental animals were compared by two-tailed t test at the mitogen or antigen concentrations routinely yielding the maximum proliferative response (ConA, 1.25 and 2.5 pug/ml; chlamydial antigen, 10:1 EB/cell ratio) and were considered significantly different at the level of P < 0.05. In experiments measuring the production of soluble factors, activities in the supernatant preparations were compared with the activities seen by treatment with medium alone.
RESULTS
Immunization with C. psittaci is characterized by an early, transient suppression of splenic T-cell proliferative responses. Mice immunized intramuscularly with 5,000 Chlamydia EBs exhibited splenomegaly and a pronounced increase in the total number of splenocytes per spleen. The increase in spleen size peaked by 10 days PI (at approximately 15 x 108 cells per spleen), but the size returned to normal within 30 days (data not shown). Spleen cells also were tested for their ability to respond to the T-cell mitogen ConA and to specific chlamydial antigen at several time points after infection. Spleen cells taken from immunized mice 4 days PI displayed heightened proliferative responses to ConA (Table 1) compared with the response of mock-immunized controls. However, by 10 days PI, when splenomegaly was maximal, there was a pronounced reduction in splenic T-cell responses at all concentrations of ConA tested (Table 1) . Lymphocyte responses to ConA were within the normal range by 30 days PI, concomitant with the return of normal spleen size (Table   1) .
A similar analysis of proliferative responses to chlamydial antigen revealed that proliferative responses to heat-inactivated EBs were not detectable at 4 or 10 days PI, but stimulation with EBs at a 10:1 EB/cell ratio induced a strong proliferative response by 30 days PI ( Table 2) .
Addition of Chlamydia-sensitized spleen cells suppressed the response of normal cells to mitogen. To determine if the cells from either mock-immunized or Chlamydia-immunized mice at 4, 10, and 30 days PI (Fig. 2A) . Calculation of the IL-2 concentrations present at each time point revealed that the levels of IL-2 present in supernatant preparations made using spleen cells from immunized animals were slightly lower than those detectable in similar preparations made from normal spleen cells (Fig. 2B) .
Similar analysis of cell-free supernatant preparations collected from splenocyte cultures derived from spleen cells of immunized or mock-immunized mice stimulated with chlamydial antigen (at a 10:1 EB/cell ratio) demonstrated that spleen cells of immunized mice, but not normal cells, produced low levels of IL-2 at all time points after immunization (Fig. 2B) . Although the overall level of IL-2 activity was lower than that observed after mitogen stimulation, the presence of significant levels of IL-2 was detectable before the appearance of a proliferative response to antigen, which was first demonstrable at 30 days PI (Fig. 2B) . Mitogen-stimulated immune spleen cell cultures produced IFN--y. Levels of IFN-y present in supernatant preparations were assessed both by titration of antiviral activity and by bioassay.
The levels of chlamydiastatic activity in ConA-stimulated supernatant preparations from spleen cells from immune and mock-immunized mice were assessed by activating peritoneal macrophages to restrict chlamydial replication in vitro, as described in Materials and Methods. When C. psittaci was added to thioglycolate-elicited macrophages pretreated with medium alone, evidence of parasite replication was detected 20 h after infection. Examination of Giemsa-stained cell populations (triplicate samples, 200 cells per sample) revealed that an average of 13.4% of the adherent cells contained demonstrable cytoplasmic inclusions (Fig. 3) . Supernatant fluids prepared by ConA stimulation of cells from immunized animals 10 days PI displayed marked chlamydiastatic activity at all concentrations tested (P < 0.05 compared with medium alone [Fig. 3]) . Pretreatment of macrophages with medium containing as little as 1% (vol/ vol) supernatant fluid from cells obtained from mice 10 days PI, for example, resulted in only 5.3% of the cells containing demonstrable inclusions (Fig. 3) . Supernatant preparations from antigen-stimulated cultures of cells from immunized animals also inhibited chlamydial growth at all dilutions tested, including substantial inhibition at a 1% (vol/vol) concentration in the medium (2.8% inclusion-containing cells [ Fig. 3]) . In at all concentrations tested (data not shown). Chlamydial replication also was reduced when the elicited macrophages were pretreated with high concentrations of supernatant fluid from ConA-stimulated cells from mock-immunized mice, indicating the presence of IFN--y in these preparations. Further dilution of this preparation, however, allowed nearmaximal chlamydial growth (Fig. 3, 12% inclusion-containing cells with 1% mock-immune supernatant), confirming by bioassay the differing levels of IFN--y present in medium from the immune and nonimmune spleen cell cultures.
Analysis of the acid-labile antiviral activity present in the supernatant preparations used in the above experiment revealed that cultures of immune spleen cells stimulated with ConA contained higher levels of IFN--y than did similarly stimulated normal spleen cells. Levels of IFN--y detected by this method in supernatant preparations were measured at 51 U/ml for immune cells and 7.4 U/ml for control cells. Immune spleen cells stimulated with EBs (10:1 EB/cell ratio) also produced detectable levels of IFN--y (17 U/ml), while similarly stimulated control cells produced <1 U of IFN--y per ml.
Mitogen-stimulated immune spleen cell supernatant preparations exhibited cytotoxic activity. (Fig. 4) . However, the levels of L-cell lysis after treatment with the ConA supernatant preparations from immunized mice were significantly higher (P < 0.05 at all dilutions) than those observed with the control ConA supernatants at all dilutions tested (Fig. 4) . Cell-free supernatant preparations from immune splenocytes stimulated with heatinactivated chlamydial antigen (EB) also contained detectable levels of cytotoxic activity for Chlamydia-infected L cells (Fig. 4) proliferative response to antigen, suggesting that the cells were specifically stimulated by antigen during the period of development of immunity.
These data suggest that a complex pattern of immune responses is stimulated after the administration of viable Chlamydia organisms to competent hosts. At least part of this process appears to involve the selective modulation of T-cell responses such that certain cellular activities (proliferation) are suppressed while others (lymphokine production) remain intact. The suppression of proliferative responses is dependent on an active cellular compohent found in spleens of immunized animals. We do not yet know what aspects of the host response contribute to the down regulation of mitogen responsiveness observed during the period after infection with C. psittaci. One possibility is that the infection of macrophages and the subsequent presentation of chlamydial antigen by these cells either fails to provide or interferes with the signal(s) necessary to induce proliferation of immune splenocytes but can serve as a sufficient and effective signal for initiation of lymphokine production by stimulated cells. This possibility is strengthened by our recent observation of a temporal relationship between the establishment of protective immunity and the induction of activated macrophages in vivo (12 (9, 11) , an observation that mirrors the experimental results presented here. The molecular mechanisms of the selective modulation observed in our system are currently being determined.
In summary, we have demonstrated the presence of marked suppression of spleen cell blastogenic responses in animals immunized with viable Chlamydia organisms. However, the capability for production of a variety of soluble factors by these cells was at or near normal levels in these animals even at the time when spleen cell proliferation was reduced. In our system, this uncoupling of lymphokine production and proliferation does not appear to be solely a pathogen-associated event but rather is associated with the administration of a dose and form of the organism that routinely leads to development of immunity. These results suggest that, in contrast to a number of human and animal bacterial infections in which detectable suppression of the host immune response has correlated with increased pathogen virulence (13, 14, 24) , immunosuppression after immunization with C. psittaci may be indicative of immune response modulation which functions in the development of protective immunity. Our current experiments are aimed at determining whether these events are linked functionally and genetically.
